MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 228 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,335,000 | -43.8% | 1,733,500 | -30.1% | 0.04% | -44.3% |
| Q2 2023 | $30,846,288 | +46.1% | 2,481,600 | +64.7% | 0.08% | +46.3% |
| Q1 2023 | $21,114,471 | +31.3% | 1,507,100 | +34.1% | 0.05% | +20.0% |
| Q4 2022 | $16,080,147 | +37.4% | 1,123,700 | +145.2% | 0.04% | +32.4% |
| Q3 2022 | $11,700,000 | +40.8% | 458,300 | +56.7% | 0.03% | +41.7% |
| Q2 2022 | $8,310,000 | +102.2% | 292,500 | +151.1% | 0.02% | +118.2% |
| Q1 2022 | $4,109,000 | +222.5% | 116,500 | +283.2% | 0.01% | +266.7% |
| Q4 2021 | $1,274,000 | +363.3% | 30,400 | +442.9% | 0.00% | +200.0% |
| Q3 2021 | $275,000 | -86.6% | 5,600 | -90.3% | 0.00% | -83.3% |
| Q1 2021 | $2,053,000 | +28.4% | 57,600 | +1.1% | 0.01% | +50.0% |
| Q4 2020 | $1,599,000 | – | 57,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |